Glenview Capital Management’s Rapid Micro Biosystems RPID Stock Holding History

Glenview Capital Management’s Portfolio RPID Stock Details RPID Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-547,990	Closed	-$488K	–	47
2024 Q3	$488K	Sell	547,990 -652,798	-54%	-$507K	0.01%	45
2024 Q2	$793K	Sell	1,200,788 -117,500	-9%	-$100K	0.02%	46
2024 Q1	$1.28M	Hold	1,318,288	–	–	0.02%	43
2023 Q4	$976K	Hold	1,318,288	–	–	0.02%	42
2023 Q3	$1.42M	Hold	1,318,288	–	–	0.03%	49
2023 Q2	$1.32M	Buy	1,318,288 +500,000	+61%	+$506K	0.03%	46
2023 Q1	$1.07M	Buy	818,288 +7,897	+1%	+$10.3K	0.02%	51
2022 Q4	$916K	Buy	810,391 +60,391	+8%	+$146K	0.02%	52
2022 Q3	$2.42M	Hold	750,000	–	–	0.06%	51
2022 Q2	$3.23M	Buy	750,000 +84,193	+13%	+$392K	0.08%	52
2022 Q1	$4.52M	Buy	+665,807	New	+$4.9M	0.09%	54

Other funds holding RPID

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

AWGLSCP

ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

Glenview Capital Management's RPID Position: Q4 2024 in Review

Glenview Capital Management sold out of Rapid Micro Biosystems (RPID) in Q4 2024, closing a stake of 547,990 shares — an estimated $488K sold.

Glenview Capital Management first reported a position in RPID in Q1 2022 and held it in 11 quarters. The position peaked at $4.52M in Q1 2022. 19 funds tracked by Wall St. Rank hold RPID as of Q4 2024.

Glenview Capital Management reported no remaining Rapid Micro Biosystems position as of Q4 2024 after selling out during the quarter.
Glenview Capital Management sold 547,990 Rapid Micro Biosystems shares in Q4 2024, an estimated $488K.
Glenview Capital Management first reported a position in Rapid Micro Biosystems in Q1 2022 and held it in 11 quarters.
Glenview Capital Management's Rapid Micro Biosystems position peaked at $4.52M in Q1 2022.
19 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q4 2024.

Based on Glenview Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.